Accelerated epigenetic aging and prospective morbidity and mortality among U.S. veterans.
Abstract
Epigenetic aging measures have promise as surrogate health outcomes in randomized control trials and observational cohort studies. The value of these measures, however, will reflect the extent to which they are associated with prospective health outcomes in real-world medical settings.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper claims that accelerated epigenetic aging is associated with prospective morbidity and mortality among U.S. veterans. This research is relevant as it explores epigenetic aging measures, which may provide insights into the underlying mechanisms of aging and their implications for health outcomes.
Author of this paper? Send a correction.